PetMed Express, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
January 24, 2022 at 04:00 pm EST
Share
PetMed Express, Inc. reported earnings results for the third quarter and nine months ended December 31, 2021. For the third quarter, the company reported sales was USD 60.72 million compared to USD 65.9 million a year ago. Net income was USD 4.26 million compared to USD 7.61 million a year ago. Basic earnings per share from continuing operations was USD 0.21 compared to USD 0.38 a year ago. Diluted earnings per share from continuing operations was USD 0.21 compared to USD 0.38 a year ago.
For the nine months, sales was USD 207.42 million compared to USD 237.54 million a year ago. Net income was USD 15.03 million compared to USD 23.79 million a year ago. Basic earnings per share from continuing operations was USD 0.75 compared to USD 1.19 a year ago. Diluted earnings per share from continuing operations was USD 0.74 compared to USD 1.18 a year ago.
PetMed Express, Inc., doing business as PetMeds, is a direct-to-consumer pet pharmacy. The Company is an online provider of prescription and non-prescription medications, food, supplements, and supplies and has veterinary and pet insurance service partnerships for dogs, cats, and horses. It markets and sells directly to consumers through their Websites, toll-free numbers, and employer benefit partnerships. Its product line contains over 15,000 SKUs of pet medications, health products, foods, and supplies. The Company offers various pet supplies, including beds, crates, stairs and other pet supplies. Its products include Prescription Medications (Rx), Non-Prescription Medications (OTC) and supplies, Pet Foods, Private Label and Holistic Wellness Services. Rx includes heartworm and flea and ticks preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
PETMED EXPRESS, INC. 
